Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from RLX Technology ( (RLX) ).
On August 22, 2025, RLX Technology announced its unaudited financial results for the second quarter of 2025, showcasing significant growth. The company reported net revenues of RMB880.0 million, a 40.3% increase from the same period in 2024, driven by international market expansion. The gross margin improved to 27.5%, and non-GAAP income from operations surged by 147.6% year-over-year. The company’s strategic focus on global compliance, data-driven localized strategies, and international distribution partnerships has reinforced its leadership in the evolving e-vapor industry, positioning it for sustainable growth and long-term shareholder value.
The most recent analyst rating on (RLX) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on RLX Technology stock, see the RLX Stock Forecast page.
Spark’s Take on RLX Stock
According to Spark, TipRanks’ AI Analyst, RLX is a Neutral.
RLX Technology’s overall stock score reflects a strong financial position and positive earnings call highlights, tempered by technical analysis indicating a lack of clear momentum and valuation concerns. The company’s strategic focus on international markets and product innovation is promising, but regulatory challenges and industry-wide revenue declines pose risks.
To see Spark’s full report on RLX stock, click here.
More about RLX Technology
RLX Technology Inc. is a leading global branded e-vapor company that leverages its strong in-house technology and product development capabilities to create superior e-vapor products. The company focuses on understanding the needs of adult smokers to develop its offerings.
Average Trading Volume: 3,142,901
Technical Sentiment Signal: Buy
Current Market Cap: $2.73B
See more insights into RLX stock on TipRanks’ Stock Analysis page.